The translocator protein 18 kda (TSPO) and its role in mitochondrial biology and psychiatric disorders

Mini-Reviews in Medicinal Chemistry

Volumn 15, Issue 5, 2015, Pages 366-372

  Milenkovic, Vladimir M ^a   Rupprecht, Rainer ^a   Wetzel, Christian H ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cholesterol; Mitochondria; PK11195; TSPO; XBD 173

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR ASSOCIATED PROTEIN I; CARRIER PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; HEXOKINASE 1; INTERLEUKIN 1; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; REACTIVE OXYGEN METABOLITE; TSPO PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL; 4 AMINOBUTYRIC ACID RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; ISOQUINOLINE DERIVATIVE; LIGAND; NEUROLEPTIC AGENT; TSPO PROTEIN, HUMAN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY DISORDER; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; HUMAN; HUNTINGTON CHOREA; MENTAL DISEASE; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; STEROIDOGENESIS; UPREGULATION; CHEMISTRY; DEGENERATIVE DISEASE; GENETICS; MENTAL DISORDERS; METABOLISM; MITOCHONDRION; PATHOLOGY;

ANTIPSYCHOTIC AGENTS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; ISOQUINOLINES; LIGANDS; MENTAL DISORDERS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; RECEPTORS, GABA;

EID: 84928948380     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557515666150324122642     Document Type: Article

References (87)

1. Li, H.; Yao, Z.; Degenhardt, B.; Teper, G.; Papadopoulos, V., Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus(CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc. Natl. Acad. Sci. U.S.A., 2001, 98(3), 1267-1272.
2. Papadopoulos, V.; Baraldi, M.; Guilarte, T. R.; Knudsen, T. B.; Lacapere, J. J.; Lindemann, P.; Norenberg, M. D.; Nutt, D.; Weizman, A.; Zhang, M. R.; Gavish, M., Translocator protein(18kDa): new nomenclature for the peripheral type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci., 2006, 27(8), 402-409.
3. Anholt, R. R.; Pedersen, P. L.; De Souza, E. B.; Snyder, S. H., The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem., 1986, 261(2), 576-583.
4. Veenman, L.; Papadopoulos, V.; Gavish, M., Channel-like functions of the 18-kDa translocator protein(TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr. Pharm. Des., 2007, 13(23), 2385-2405
5. Lacapere, J. J.; Papadopoulos, V., Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids, 2003, 68(7-8), 569-585.
6. Papadopoulos, V.; Liu, J.; Culty, M., Is there a mitochondrial signaling complex facilitating cholesterol import? Mol. Cell Endocrinol., 2007, 265-266, 59-64.
7. Scarf, A. M.; Ittner, L. M.; Kassiou, M., The translocator protein(18 kDa): central nervous system disease and drug design. J. Med. Chem., 2009, 52(3), 581-592.
8. Hauet, T.; Yao, Z. X.; Bose, H. S.; Wall, C. T.; Han, Z.; Li, W.; Hales, D. B.; Miller, W. L.; Culty, M.; Papadopoulos, V., Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Mol. Endocrinol., 2005, 19(2), 540-554.
9. Liu, J.; Li, H.; Papadopoulos, V., PAP7, a PBR/PKA-RIalphaassociated protein: a new element in the relay of the hormonal induction of steroidogenesis. J. Steroid Biochem. Mol. Biol., 2003, 85(2-5), 275-283.
10. Galiegue, S.; Jbilo, O.; Combes, T.; Bribes, E.; Carayon, P.; Le Fur, G.; Casellas, P., Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J. Biol. Chem., 1999, 274(5), 2938-2952.
11. Dolle, F.; Luus, C.; Reynolds, A.; Kassiou, M., Radiolabelled molecules for imaging the translocator protein(18 kDa) using positron emission tomography. Curr. Med. Chem., 2009, 16(22), 2899-2923.
12. Chauveau, F.; Boutin, H.; Van Camp, N.; Dolle, F.; Tavitian, B., Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J. Nucl. Med. Mol. Imaging, 2008, 35(12), 2304-2319.
13. Campiani, G.; Ramunno, A.; Fiorini, I.; Nacci, V.; Morelli, E.; Novellino, E.; Goegan, M.; Mennini, T.; Sullivan, S.; Zisterer, D. M.; Williams, C. D., Synthesis of new molecular probes for investigation of steroid biosynthesis induced by selective interaction with peripheral type benzodiazepine receptors(PBR). J. Med. Chem. 2002, 45(19), 4276-81.
14. Casellas, P.; Galiegue, S.; Basile, A. S., Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Int., 2002, 40(6), 475-486.
15. Sutter, A. P.; Maaser, K.; Hopfner, M.; Barthel, B.; Grabowski, P.; Faiss, S.; Carayon, P.; Zeitz, M.; Scherubl, H., Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells. Int. J. Cancer, 2002, 102(4), 318-327.
16. Fan, J.; Lindemann, P.; Feuilloley, M. G.; Papadopoulos, V., Structural and functional evolution of the translocator protein(18 kDa). Curr. Mol. Med., 2012, 12(4), 369-386.
17. Riond, J.; Leplatois, P.; Laurent, P.; Le Fur, G.; Caput, D.; Loison, G.; Ferrara, P., Expression and pharmacological characterization of the human peripheral-type benzodiazepine receptor in yeast. Eur. J. Pharmacol., 1991, 208(4), 307-312.
18. Fan, J.; Rone, M. B.; Papadopoulos, V., Translocator protein 2 is involved in cholesterol redistribution during erythropoiesis. J. Biol. Chem., 2009, 284(44), 30484-30497.
19. Riond, J.; Mattei, M. G.; Kaghad, M.; Dumont, X.; Guillemot, J. C.; Le Fur, G.; Caput, D.; Ferrara, P., Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor. Eur. J Biochem., 1991, 195(2), 305-311.
20. Rone, M. B.; Liu, J.; Blonder, J.; Ye, X.; Veenstra, T. D.; Young, J. C.; Papadopoulos, V., Targeting and insertion of the cholesterolbinding translocator protein into the outer mitochondrial membrane. Biochemistry, 2009, 48(29), 6909-6920.
21. Joseph-Liauzun, E.; Delmas, P.; Shire, D.; Ferrara, P., Topological analysis of the peripheral benzodiazepine receptor in yeast mitochondrial membranes supports a five-transmembrane structure. J. Biol. Chem., 1998, 273(4), 2146-2152.
22. Li, H.; Papadopoulos, V., Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology, 1998, 139(12), 4991-4997.
23. Farges, R.; Joseph-Liauzun, E.; Shire, D.; Caput, D.; Le Fur, G.; Ferrara, P., Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864. Mol. Pharmacol., 1994, 46(6), 1160-1167.
24. Anzini, M.; Cappelli, A.; Vomero, S.; Seeber, M.; Menziani, M. C.; Langer, T.; Hagen, B.; Manzoni, C.; Bourguignon, J. J., Mapping and fitting the peripheral benzodiazepine receptor binding site by carboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modeling. J. Med. Chem., 2001, 44(8), 1134-1150.
25. Owen, D. R.; Yeo, A. J.; Gunn, R. N.; Song, K.; Wadsworth, G.; Lewis, A.; Rhodes, C.; Pulford, D. J.; Bennacef, I.; Parker, C. A.; StJean, P. L.; Cardon, L. R.; Mooser, V. E.; Matthews, P. M.; Rabiner, E. A.; Rubio, J. P., An 18-kDa translocator protein(TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J. Cereb. Blood Flow Metab., 2012, 32(1), 1-5.
26. Korkhov, V. M.; Sachse, C.; Short, J. M.; Tate, C. G., Threedimensional structure of TspO by electron cryomicroscopy of helical crystals. Structure, 2010, 18(6), 677-687.
27. Jaremko, L.; Jaremko, M.; Giller, K.; Becker, S.; Zweckstetter, M., Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science, 2014, 343(6177), 1363-1366.
28. Krueger, K. E.; Papadopoulos, V., Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J. Biol. Chem., 1990, 265(25), 15015-15022.
29. Lacapere, J. J.; Delavoie, F.; Li, H.; Peranzi, G.; Maccario, J.; Papadopoulos, V.; Vidic, B., Structural and functional study of reconstituted peripheral benzodiazepine receptor. Biochem. Biophys. Res. Commun., 2001, 284(2), 536-541.
30. Gavish, M.; Bachman, I.; Shoukrun, R.; Katz, Y.; Veenman, L.; Weisinger, G.; Weizman, A., Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev., 1999, 51(4), 629-650.
31. Anholt, R. R.; Murphy, K. M.; Mack, G. E.; Snyder, S. H., Peripheral-type benzodiazepine receptors in the central nervous system: localization to olfactory nerves. J. Neurosci., 1984, 4(2), 593-603.
32. Papadopoulos, V., Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr. Rev., 1993, 14(2), 222-240.
33. Garnier, M.; Boujrad, N.; Ogwuegbu, S. O.; Hudson, J. R., Jr.; Papadopoulos, V., The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem., 1994, 269(35), 22105-22112.
34. Kelly-Hershkovitz, E.; Weizman, R.; Spanier, I.; Leschiner, S.; Lahav, M.; Weisinger, G.; Gavish, M., Effects of peripheral-type benzodiazepine receptor antisense knockout on MA-10 Leydig cell proliferation and steroidogenesis. J. Biol. Chem., 1998, 273(10), 5478-5483.
35. Papadopoulos, V.; Amri, H.; Boujrad, N.; Cascio, C.; Culty, M.; Garnier, M.; Hardwick, M.; Li, H.; Vidic, B.; Brown, A. S.; Reversa, J.L.; Bernassau, J.M.; Drieu, K., Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids, 1997, 62(1), 21-28.
36. Morohaku, K.; Pelton, S. H.; Daugherty, D. J.; Butler, W. R.; Deng, W.; Selvaraj, V., Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology, 2014, 155(1), 89-97.
37. Sileikyte, J.; Blachly-Dyson, E.; Sewell, R.; Carpi, A.; Menabo, R.; Di Lisa, F.; Ricchelli, F.; Bernardi, P.; Forte, M., Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (Translocator Protein of 18 kDa(TSPO)). J. Biol. Chem., 2014, 289(20), 13769-13781.
38. Tu, L. N.; Morohaku, K.; Manna, P. R.; Pelton, S. H.; Butler, W. R.; Stocco, D. M.; Selvaraj, V., Peripheral Benzodiazepine Receptor/Translocator Protein Global Knock-out Mice Are Viable with No Effects on Steroid Hormone Biosynthesis. J. Biol. Chem., 2014, 289(40), 27444-27454.
39. Hirsch, J. D.; Beyer, C. F.; Malkowitz, L.; Beer, B.; Blume, A. J., Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol. Pharmacol., 1989, 35(1), 157-163.
40. Larcher, J. C.; Vayssiere, J. L.; Le Marquer, F. J.; Cordeau, L. R.; Keane, P. E.; Bachy, A.; Gros, F.; Croizat, B. P., Effects of peripheral benzodiazepines upon the O2 consumption of neuroblastoma cells. Eur. J. Pharmacol., 1989, 161(2-3), 197-202.
41. Gatliff, J.; Campanella, M., The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology. Curr. Mol. Med., 2012, 12(4), 356-368.
42. Zeno, S.; Zaaroor, M.; Leschiner, S.; Veenman, L.; Gavish, M., CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells. Biochemistry, 2009, 48(21), 4652-4661.
43. Veenman, L.; Shandalov, Y.; Gavish, M., VDAC activation by the 18 kDa translocator protein(TSPO), implications for apoptosis. J. Bioenerg. Biomembr., 2008, 40(3), 199-205.
44. Delavoie, F.; Li, H.; Hardwick, M.; Robert, J. C.; Giatzakis, C.; Peranzi, G.; Yao, Z.X.; Maccario, J.; Lacapere, J.J.; Papadopoulos, V., In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry, 2003, 42(15), 4506-4519.
45. Boujrad, N.; Vidic, B.; Papadopoulos, V., Acute action of choriogonadotropin on Leydig tumor cells: changes in the topography of the mitochondrial peripheral-type benzodiazepine receptor. Endocrinology, 1996, 137(12), 5727-5730.
46. Rupprecht, R., Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology, 2003, 28(2), 139-168.
47. Nudmamud, S.; Siripurkpong, P.; Chindaduangratana, C.; Harnyuttanakorn, P.; Lotrakul, P.; Laarbboonsarp, W.; Srikiatkhachorn, A.; Kotchabhakdi, N.; Casalotti, S. O., Stress, anxiety and peripheral benzodiazepine receptor mRNA levels in human lymphocytes. Life Sci., 2000, 67(18), 2221-2231.
48. Rocca, P.; Beoni, A. M.; Eva, C.; Ferrero, P.; Zanalda, E.; Ravizza, L., Peripheral benzodiazepine receptor messenger RNA is decreased in lymphocytes of generalized anxiety disorder patients. Biol. Psychiatry, 1998, 43(10), 767-73.
49. Gavish, M.; Laor, N.; Bidder, M.; Fisher, D.; Fonia, O.; Muller, U.; Reiss, A.; Wolmer, L.; Karp, L.; Weizman, R., Altered platelet peripheral-type benzodiazepine receptor in posttraumatic stress disorder. Neuropsychopharmacol., 1996, 14(3), 181-186.
50. Abelli, M.; Chelli, B.; Costa, B.; Lari, L.; Cardini, A.; Gesi, C.; Muti, M.; Lucacchini, A.; Martini, C.; Cassano, G. B.; Pini, S., Reductions in platelet 18-kDa translocator protein density are associated with adult separation anxiety in patients with bipolar disorder. Neuropsychobiology, 2010, 62(2), 98-103.
51. Pini, S.; Martini, C.; Abelli, M.; Muti, M.; Gesi, C.; Montali, M.; Chelli, B.; Lucacchini, A.; Cassano, G. B., Peripheral-type benzodiazepine receptor binding sites in platelets of patients with panic disorder associated to separation anxiety symptoms. Psychopharmacology(Berl), 2005, 181(2), 407-411.
52. Ritsner, M.; Modai, I.; Gibel, A.; Leschiner, S.; Silver, H.; Tsinovoy, G.; Weizman, A.; Gavish, M., Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients. J. Psychiatr. Res., 2003, 37(6), 549-556.
53. Chelli, B.; Pini, S.; Abelli, M.; Cardini, A.; Lari, L.; Muti, M.; Gesi, C.; Cassano, G. B.; Lucacchini, A.; Martini, C., Platelet 18 kDa Translocator Protein density is reduced in depressed patients with adult separation anxiety. Eur. Neuropsychopharmacol., 2008, 18(4), 249-254.
54. Weizman, A.; Burgin, R.; Harel, Y.; Karp, L.; Gavish, M., Platelet peripheral-type benzodiazepine receptor in major depression. J. Affect. Disord., 1995, 33(4), 257-261.
55. Costa, B.; Pini, S.; Martini, C.; Abelli, M.; Gabelloni, P.; Landi, S.; Muti, M.; Gesi, C.; Lari, L.; Cardini, A.; Galderisi, S.; Mucci, A.; Lucacchini, A.; Cassano, G. B., Ala147Thr substitution in translocator protein is associated with adult separation anxiety in patients with depression. Psychiatr. Genet., 2009, 19(2), 110-111.
56. Costa, B.; Pini, S.; Gabelloni, P.; Da Pozzo, E.; Abelli, M.; Lari, L.; Preve, M.; Lucacchini, A.; Cassano, G. B.; Martini, C., The spontaneous Ala147Thr amino acid substitution within the translocator protein influences pregnenolone production in lymphomonocytes of healthy individuals. Endocrinology, 2009, 150(12), 5438-5445.
57. Rupprecht, R.; Papadopoulos, V.; Rammes, G.; Baghai, T. C.; Fan, J.; Akula, N.; Groyer, G.; Adams, D.; Schumacher, M., Translocator protein(18 kDa)(TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov., 2010, 9(12), 971-988.
58. Edison, P.; Archer, H. A.; Gerhard, A.; Hinz, R.; Pavese, N.; Turkheimer, F. E.; Hammers, A.; Tai, Y. F.; Fox, N.; Kennedy, A.; Rossor, M.; Brooks, D. J., Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R) PK11195-PET and [11C]PIBPET study. Neurobiol. Dis., 2008, 32(3), 412-419.
59. Pavese, N.; Gerhard, A.; Tai, Y. F.; Ho, A. K.; Turkheimer, F.; Barker, R. A.; Brooks, D. J.; Piccini, P., Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology, 2006, 66(11), 1638-1643.
60. Turner, M. R.; Cagnin, A.; Turkheimer, F. E.; Miller, C. C.; Shaw, C. E.; Brooks, D. J.; Leigh, P. N.; Banati, R. B., Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis., 2004, 15(3), 601-609.
61. Ouchi, Y.; Yoshikawa, E.; Sekine, Y.; Futatsubashi, M.; Kanno, T.; Ogusu, T.; Torizuka, T., Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann. Neurol., 2005, 57(2), 168-75.
62. Vowinckel, E.; Reutens, D.; Becher, B.; Verge, G.; Evans, A.; Owens, T.; Antel, J. P., PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neurosci. Res., 1997, 50(2), 345-353.
63. Gerhard, A.; Schwarz, J.; Myers, R.; Wise, R.; Banati, R. B., Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage, 2005, 24(2), 591-595.
64. Papadopoulos, V.; Lecanu, L., Translocator protein(18 kDa) TSPO: an emerging therapeutic target in neurotrauma. Exp. Neurol., 2009, 219(1), 53-57.
65. Ji, B.; Maeda, J.; Sawada, M.; Ono, M.; Okauchi, T.; Inaji, M.; Zhang, M. R.; Suzuki, K.; Ando, K.; Staufenbiel, M.; Trojanowski, J. Q.; Lee, V. M.; Higuchi, M.; Suhara, T., Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. J. Neurosci., 2008, 28(47), 12255-12267.
66. Batarseh, A.; Papadopoulos, V., Regulation of translocator protein 18 kDa(TSPO) expression in health and disease states. Mol. Cell Endocrinol., 2010, 327(1-2), 1-12.
67. Lihrmann, I.; Plaquevent, J. C.; Tostivint, H.; Raijmakers, R.; Tonon, M. C.; Conlon, J. M.; Vaudry, H., Frog diazepam-binding inhibitor: peptide sequence, cDNA cloning, and expression in the brain. Proc. Natl. Acad. Sci. U. S. A., 1994, 91(15), 6899-6903
68. Besman, M. J.; Yanagibashi, K.; Lee, T. D.; Kawamura, M.; Hall, P. F.; Shively, J. E., Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc. Natl. Acad. Sci. U.S.A., 1989, 86(13), 4897-4901.
69. Papadopoulos, V.; Berkovich, A.; Krueger, K. E.; Costa, E.; Guidotti, A., Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology, 1991, 129(3), 1481-1488.
70. Tokay, T.; Hachem, R.; Masmoudi-Kouki, O.; Gandolfo, P.; Desrues, L.; Leprince, J.; Castel, H.; Diallo, M.; Amri, M.; Vaudry, H.; Tonon, M. C., Beta amyloid peptide stimulates endozepine release in cultured rat astrocytes through activation of N-formyl peptide receptors. Glia, 2008, 56(13), 1380-1389.
71. Verma, A.; Snyder, S. H., Peripheral type benzodiazepine receptors. Ann. Rev. Pharmacol. Toxicol., 1989, 29, 307-322.
72. Banati, R. B., Visualising microglial activation in vivo. Glia, 2002, 40(2), 206-217.
73. Le Fur, G.; Guilloux, F.; Rufat, P.; Benavides, J.; Uzan, A.; Renault, C.; Dubroeucq, M. C.; Gueremy, C., Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2- chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies. Life Sci,. 1983, 32(16), 1849-1856.
74. Marangos, P. J.; Patel, J.; Boulenger, J. P.; Clark-Rosenberg, R., Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. Mol. Pharmacol., 1982, 22(1), 26-32.
75. Awad, M.; Gavish, M., Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites. J. Neurochem., 1987, 49(5), 1407-1414.
76. Scarf, A. M.; Luus, C.; Da Pozzo, E.; Selleri, S.; Guarino, C.; Martini, C.; Ittner, L. M.; Kassiou, M., Evidence for complex binding profiles and species differences at the translocator protein(TSPO)(18 kDa). Curr. Mol. Med., 2012, 12(4), 488-493.
77. Scarf, A. M.; Auman, K. M.; Kassiou, M., Is there any correlation between binding and functional effects at the translocator protein(TSPO)(18 kDa)? Curr. Mol. Med., 2012, 12(4), 387-397.
78. Giatti, S.; Pesaresi, M.; Cavaletti, G.; Bianchi, R.; Carozzi, V.; Lombardi, R.; Maschi, O.; Lauria, G.; Garcia-Segura, L. M.; Caruso, D.; Melcangi, R. C., Neuroprotective effects of a ligand of translocator protein-18 kDa(Ro5-4864) in experimental diabetic neuropathy. Neuroscience, 2009, 164(2), 520-529.
79. Aouad, M.; Charlet, A.; Rodeau, J. L.; Poisbeau, P., Reduction and prevention of vincristine-induced neuropathic pain symptoms by the non-benzodiazepine anxiolytic etifoxine are mediated by 3alpha-reduced neurosteroids. Pain, 2009, 147(1-3), 54-59.
80. Girard, C.; Liu, S.; Cadepond, F.; Adams, D.; Lacroix, C.; Verleye, M.; Gillardin, J. M.; Baulieu, E. E.; Schumacher, M.; Schweizer- Groyer, G., Etifoxine improves peripheral nerve regeneration and functional recovery. Proc. Natl. Acad. Sci. U.S.A., 2008, 105(51), 20505-20510.
81. Hamon, A.; Morel, A.; Hue, B.; Verleye, M.; Gillardin, J. M., The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunit. Neuropharmacology, 2003, 45(3), 293-303.
82. Choi, J.; Ifuku, M.; Noda, M.; Guilarte, T. R., Translocator protein(18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state. Glia, 2011, 59(2), 219-230.
83. Costa, B.; Da Pozzo, E.; Chelli, B.; Simola, N.; Morelli, M.; Luisi, M.; Maccheroni, M.; Taliani, S.; Simorini, F.; Da Settimo, F.; Martini, C., Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity. Psychoneuroendocrinology, 2011, 36(4), 463-472.
84. Nguyen, N.; Fakra, E.; Pradel, V.; Jouve, E.; Alquier, C.; Le Guern, M. E.; Micallef, J.; Blin, O., Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice. Hum. Psychopharmacol., 2006, 21(3), 139-149.
85. Rupprecht, R.; Rammes, G.; Eser, D.; Baghai, T. C.; Schule, C.; Nothdurfter, C.; Troxler, T.; Gentsch, C.; Kalkman, H. O.; Chaperon, F.; Uzunov, V.; McAllister, K. H.; Bertaina-Anglade, V.; La Rochelle, C. D.; Tuerck, D.; Floesser, A.; Kiese, B.; Schumacher, M.; Landgraf, R.; Holsboer, F.; Kucher, K., Translocator protein(18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science, 2009, 325(5939), 490-493.
86. Omasits, U.; Ahrens, C. H.; Muller, S.; Wollscheid, B., Protter: interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics, 2014, 30(6), 884-886.
87. Yeliseev, A. A.; Kaplan, S., TspO of rhodobacter sphaeroides. A structural and functional model for the mammalian peripheral benzodiazepine receptor. J. Biol. Chem., 2000, 275(8), 5657-5667.